Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Approves Takeda’s Hyqvia for Maintenance of Chronic Inflammatory Demyelinating Polyneuropathy

Hyqvia is the only subcutaneous immune globulin infusion that can be administered once per month.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *